Hans-Dieter Volk

This inventor holds 13 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 9 EPO patents. Top assignees: Charité – Universitätsmedizin Berlin, Aicuris Gmbh + Co. Kg., Berlin-Chemie Ag. Active years: 1997-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Dieter Volk. Retrieved from https://idiyas.com/inventor/hans-dieter-volk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 11)

% Patents Active = 38.5

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 21)

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 72(Granted Patents)

Company Filing History:

4 out of 283

Charité – Universitätsmedizin Berlin

patents

3 out of 53

Aicuris Gmbh + Co. Kg.

4. 5 out of 834,513

Other

patents

Years Active: 1997-2023

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11802873 - CD8 T cell subsets as a biomarker for predicting non-fusion after spinal fusion surgery (2023-10-31),

2. 11639935 - CD8+T-cell subsets as markers for prediction of delayed fracture healing (2023-05-02),

3. 10144777 - B-lymphocyte targeting agents for use in a method for the treatment of a disease (2018-12-04),

4. 9763985 - Antigen-specific central-memory T cell preparations having high CD4+ fraction (2017-09-19),

5. 9714272 - Recombinant proteins of parapdxvirus ovis and pharmaceutical compositions therefrom (2017-07-25),

6. 8932806 - Method for identifying t-cell stimulating protein fragments (2015-01-13),

7. 8852577 - [object Object] (2014-10-07),

8. 8617560 - Peptides for vaccination against human CMV (2013-12-31),

9. 8357363 - Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom (2013-01-22),

10. 7994096 - Method for antigen-specific stimulation of T lymphocytes with synthetic peptide libraries (2011-08-09),

11. 7718425 - Use of a B-cell-depleting antibody for treatment of polyoma virus infections (2010-05-18),

12. 7041442 - Peptides for vaccinating against human CMV (2006-05-09),

13. 5656601 - Acylated splenopentins, methods for their synthesis and their use (1997-08-12),

Title: The Innovations of Hans-Dieter Volk

Introduction

Hans-Dieter Volk is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of medical research, particularly in the area of immunology. With a total of 13 patents to his name, Volk's work has the potential to impact patient care and treatment outcomes.

Latest Patents

One of his latest patents focuses on using CD8 T cell subsets as a biomarker for predicting non-fusion after spinal fusion surgery. This method involves determining the frequency of specific subpopulations of CD8+ T cells in a patient sample. Another notable patent addresses the diagnosis of delayed bone fracture healing, which also utilizes the frequency of CD8+ cells to predict healing outcomes. These innovations highlight his commitment to advancing medical diagnostics and treatment strategies.

Career Highlights

Throughout his career, Hans-Dieter Volk has worked with various organizations, including Aicuris GmbH & Co. KG. His research has led to groundbreaking discoveries that enhance our understanding of immune responses and their implications for surgical recovery and bone healing.

Collaborations

Volk has collaborated with notable colleagues such as Petra Reinke and Florian Kern. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Hans-Dieter Volk's contributions to medical research through his patents and collaborations demonstrate his dedication to improving patient outcomes. His work continues to pave the way for advancements in the field of immunology and beyond.

Profile summary based on public USPTO records.